Anthracyclines (doxorubicin, daunorubicin, and idarubicin) are very effective
chemotherapeutic drugs to treat many cancers; however, the development of multiple drug …

Prostate cancer is the most common non-cutaneous malignancy in American men.
Docetaxel is a useful chemotherapeutic agent for prostate cancer that has been available for …

Background Poly lactic-co-glycolic acid (PLGA) based nanoparticles are considered to be a
promising drug carrier in tumor targeting but suffer from the high level of opsonization by …

Aberrant signaling of the epidermal growth factor receptor (EGFR) is common to a variety of
human cancers and is also found to be over‐expressed in most cases of non‐small cell lung …

Purpose Here, we explored the formulation of a calcium carbonate nanoparticle delivery
system aimed at enhancing docetaxel (DTX) release in breast cancer. Methods The …

Glaucoma is the second leading cause of irreversible blindness worldwide. Among others,
elevated intraocular pressure (IOP) is one of the hallmarks of the disease. Antiglaucoma …

Introduction: Cancer is a leading cause of death worldwide and it is estimated that deaths
from this disease will rise to over 11 million in 2030. Most cases of cancer can be cured with …

This study aimed to investigate the sustained drug release properties and hearing protection
effect of polyethylene glycol-coated polylactic acid (PEG-PLA) stealth nanoparticles loaded …

To investigate the antitumor effect, biodistribution and penetration in tumors of docetaxel
(DOC)-loaded polyethylene glycol–poly (caprolactone)(mPEG–PCL) nanoparticles on …

Background The delivery of treatment agents to inner ear with drug delivery system (DDS)
has been under investigation to overcome the limitations of the conventional therapeutic …